Challenging VTE Standards: Heparin,
LMWHs, and Evolving Agents
Upon completion of this program, participants should be able to:
University Pharmacotherapy Associates, LLC is accredited by the American Council on Pharmaceutical Education (ACPE) as a provider of continuing education and complies with the Criteria for Quality for continuing pharmaceutical education programming. The assigned universal program number is 786-999-03-002-H01. This program provides 1.0 hours (0.1 CEU) of continuing pharmaceutical education credit. Original program release date is February 1, 2003. This program expires February 1, 2005.
interest disclosure forms are on file at UPA. If you would like a copy of this
information please contact us at email@example.com.
Upon successful completion of the entire program and post-test, participants can
print their Continuing Pharmaceutical Education Statement on line or contact UPA
at 412-380-7907 to have their document mailed to them within 45 days. A passing
score is a minimum of 4 correct questions out of 5. The entire program must be
viewed to take the post-test.
This program is an online version of a live regional activity. If you participated in the corresponding live activity, you are not eligible to receive credit for this online program.
This program has been designed for health-system pharmacists.
This program is funded by an unrestricted educational grant from Aventis Pharmaceuticals.
Click on the name below for more information about the authors
J. Vanscoy, PharmD, CACP, MBA
Chairman and CEO, University Pharmacotherapy Associates, LLC
Assistant Dean for Managed Care, Associate Professor of Pharmaceutical Sciences, University of Pittsburgh
Consulting Director of Anticoagulation Services Pittsburgh Veterans Affairs Health System
L. Rihn, PharmD
Vice President and Chief Clinical Officer, University Pharmacotherapy Associates, LLC
Associate Professor of Clinical Pharmacy, Duquesne University School of Pharmacy
Click Here to begin the CE Lesson